Delgocitinib cream is a topical pan-Janus kinase (JAK) inhibitor. Positive topline results were announced from a second phase 3 study evaluating delgocitinib cream in adult patients with moderate to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A total of 40.3% of patients treated with dupilumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results